Prognostix (Path FX)
Develops e-health decision support tools based on AI
Prognostix AB has developed a decision support tool (www.pathfx.org), capable of estimating survival in cancer patients with skeletal metastases. PATHFx is based on Machine Learning and helps physicians personalize care more effectively, thereby improving patient quality of life and reduce health care costs. PATHFx has sucessfully been tested at many renowned cancer centers globally.